BDTX Black Diamond Therapeutics, Inc. - Common Stock
$3.28
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$2–$5
45% of range
Analyst Rating
BUY
15 analysts
Price Target
$10
+201% upside
P/E (TTM)
6.2
ROE
18.3%
Net Profit Margin
31.9%
BDTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.28
Market Cap
$139M
P/E (TTM)
6.2
EPS (TTM)
$0.39
Revenue (TTM)
$70M
Div Yield
—
ROE
18.3%
Debt/Equity
—
52W Range
$2 – $5
BDTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$70M
2018-12-31
→
2025-12-31
EPS
$0.39
2020-12-31
→
2025-12-31
Free Cash Flow
—
2019-12-31
→
2024-12-31
Margins
31.9%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BDTX
Peer Median
P/E (TTM)
6.2
579.2
P/S (TTM)
2.0
14.1
P/B
1.2
2.2
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BDTX
Peer Median
Operating Margin
17.9%
—
Net Profit Margin
31.9%
-505.5%
ROA
16.8%
-57.6%
ROE
18.3%
-77.2%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BDTX
Peer Median
Current Ratio
8.4
3.6
Quick Ratio
1.3
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BDTX
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BDTX
Peer Median
BDTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
15 analysts
- Strong Buy 5 33.3%
- Buy 8 53.3%
- Hold 2 13.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
7 analysts · 2026-05-18
Median
$10.00
← Below all targets
$3.28
Low
$7.00
High
$14.00
Median target
$10.00
+204.9%
Mean target
$9.86
+200.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.18%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.16 | $-0.19 | 0.03% |
| Dec. 31, 2025 | $-0.27 | $-0.19 | -0.08% |
| Sept. 30, 2025 | $-0.15 | $-0.24 | 0.09% |
| June 30, 2025 | $-0.19 | $-0.25 | 0.06% |
| March 31, 2025 | $0.98 | $0.02 | 0.96% |
| Dec. 31, 2024 | $-0.28 | $-0.32 | 0.04% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BDTX | $139M | 6.2 | — | 31.9% | 18.3% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| HUMA | — | — | — | — | — | — |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $0 | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $34M | $51M | $59M | $64M | $97M | $48M | $22M | $7M | |
| SG&A Expense | $17M | $27M | $27M | $28M | $30M | $21M | $8M | $2M | |
| Operating Expenses | $57M | $79M | $86M | $93M | $127M | $70M | $29M | $9M | |
| Operating Income | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | $-9M | |
| Interest Expense | · | · | · | · | $0 | $1.0K | $0 | · | |
| Other Non-op | $6M | $7M | $2M | $-354.0K | $-2M | $-2M | $6.0K | $-16.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | $-9M | |
| EPS (Basic) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| EPS (Diluted) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| Shares (Basic) | 56,868,111 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| Shares (Diluted) | 57,562,746 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| EBITDA | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | · |
Balance Sheet 20
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $36M | $56M | $34M | $66M | $35M | $155M | $52M | |
| Prepaid Expense | $4M | $3M | $3M | $5M | $6M | $4M | $1M | $24.0K | |
| Current Assets | $132M | $101M | $134M | $128M | $216M | $320M | $156M | $52M | |
| PP&E (Net) | $365.0K | $1M | $2M | $3M | $3M | $385.0K | $164.0K | $134.0K | |
| PP&E (Gross) | $2M | $3M | $3M | $3M | $3M | $549.0K | $276.0K | $234.0K | |
| Accum. Depreciation | $1M | $1M | $799.0K | $750.0K | $369.0K | $164.0K | $112.0K | $100.0K | |
| Other Non-current Assets | $73.0K | $249.0K | $0 | $0 | $16.0K | $106.0K | $59.0K | $8.0K | |
| Total Assets | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Accounts Payable | $579.0K | $4M | $2M | $2M | $4M | $3M | $2M | $416.0K | |
| Accrued Liabilities | $15M | $17M | $17M | $13M | $20M | $12M | $3M | $452.0K | |
| Current Liabilities | $16M | $21M | $20M | $15M | $24M | $14M | $5M | $3M | |
| Capital Leases | $15M | $19M | $22M | $25M | $28M | $8M | · | · | |
| Total Liabilities | $31M | $39M | $42M | $41M | $52M | $22M | $5M | $7M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $1.0K | $1.0K | |
| Paid-in Capital | $577M | $570M | $534M | $453M | $440M | $425M | $4M | $169.0K | |
| Retained Earnings | $-465M | $-487M | $-417M | $-335M | $-244M | $-118M | $-51M | $-16M | |
| AOCI | $101.0K | $24.0K | $-27.0K | $-2M | $-414.0K | $614.0K | $0 | · | |
| Stockholders' Equity | $112M | $83M | $117M | $116M | $196M | $308M | $-47M | $-16M | |
| Liabilities + Equity | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Shares Outstanding | 57,138,057 | 56,644,655 | 51,645,557 | 36,434,297 | 36,234,624 | 36,078,383 | 2,236,672 | 2,173,684 |
Cash Flow 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $11M | $10M | $12M | $14M | $8M | $4M | $64.0K | |
| Restructuring | · | $3M | · | · | · | · | · | · | |
| Operating Cash Flow | $30M | $-62M | $-67M | $-85M | $-100M | $-52M | $-25M | $-8M | |
| CapEx | · | $0 | $33.0K | $192.0K | $3M | $142.0K | $21.0K | $76.0K | |
| Investing Cash Flow | $-45M | $17M | $16M | $53M | $131M | $-282M | $-21.0K | $-76.0K | |
| Stock Issued | $0 | $24M | $72M | $0 | · | · | · | · | |
| Net Stock Activity | $0 | $24M | $72M | · | · | · | · | · | |
| Financing Cash Flow | $-146.0K | $26M | $72M | $177.0K | $729.0K | $215M | $128M | $52M | |
| Net Change in Cash | $-15M | $-20M | $22M | $-32M | $31M | $-119M | $103M | $44M | |
| Free Cash Flow | · | $-62M | $-67M | $-85M | $-103M | $-52M | $-25M | · |
Profitability 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.9% | · | · | · | · | · | · | · | |
| Net Margin | 31.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | 17.9% | · | · | · | · | · | · | · | |
| ROA | 16.8% | -49.5% | -52.4% | -45.1% | -43.5% | -27.6% | -33.6% | · | |
| ROE | 18.3% | -77.1% | -65.7% | -73.2% | -60.6% | -21.2% | 81.1% | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 | 22.5 | 32.0 | · | |
| Quick Ratio | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 | 2.4 | 31.8 | · | |
| Interest Coverage | · | · | · | · | · | -69570.0 | · | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | · | · | · | 0.0 | 0.0 | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | · | |
| Market Cap | $139M | $121M | $145M | $66M | $193M | $1.16B | · | · | |
| P/E | 6.2 | -1.7 | -1.5 | -0.7 | -1.5 | -15.6 | · | · | |
| P/S | 2.0 | · | · | · | · | · | · | · | |
| P/B | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Tangible Book | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Cash Flow | 4.7 | -1.9 | -2.2 | -0.8 | -1.9 | -22.2 | · | · | |
| P / FCF | · | -1.9 | -2.2 | -0.8 | -1.9 | -22.1 | · | · | |
| Earnings Yield | 16.1% | -59.4% | -66.9% | -140.0% | -65.1% | -6.4% | · | · |
Income Statement 13
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $70M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| R&D Expense | $7M | $6M | $7M | $9M | $11M | $12M | $13M | $13M | $14M | $15M | $16M | $13M | $15M | $15M | $16M | $16M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $5M | $6M | $5M | $10M | $7M | $6M | $8M | $7M | $7M | $7M | $6M | $7M | |
| Operating Expenses | $11M | $18M | $11M | $13M | $15M | $18M | $18M | $22M | $20M | $21M | $24M | $20M | $22M | $22M | $22M | $23M | |
| Operating Income | $-11M | $-18M | $-11M | $-13M | $55M | $-18M | $-18M | $-22M | $-20M | $-21M | $-24M | $-20M | $-22M | $-22M | $-22M | $-23M | |
| Other Non-op | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $566.0K | $341.0K | $64.0K | $115.0K | $-92.0K | $-143.0K | |
| Income Tax | · | · | · | $0 | $226.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-15M | $-8M | $-11M | $57M | $-16M | $-16M | $-20M | $-18M | $-19M | $-23M | $-19M | $-21M | $-21M | $-22M | $-23M | |
| EPS (Basic) | $-0.16 | $-0.27 | $-0.15 | $-0.19 | $1.00 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | $-0.63 | |
| EPS (Diluted) | $-0.16 | $-0.25 | $-0.15 | $-0.19 | $0.98 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | $-0.63 | |
| Shares (Basic) | 57,233,413 | -113,528,240 | 56,929,103 | 56,803,450 | 56,663,798 | -108,443,654 | 56,507,956 | 55,155,220 | 51,808,849 | -79,988,498 | 50,943,155 | 36,516,114 | 36,483,878 | -72,585,742 | 36,346,181 | 36,293,856 | |
| Shares (Diluted) | 57,233,413 | -113,842,906 | 56,929,103 | 56,803,450 | 57,673,099 | -108,443,654 | 56,507,956 | 55,155,220 | 51,808,849 | -79,988,498 | 50,943,155 | 36,516,114 | 36,483,878 | -72,585,742 | 36,346,181 | 36,293,856 | |
| EBITDA | $-11M | · | $-11M | $-13M | $55M | · | $-18M | $-22M | $-20M | · | $-24M | $-20M | $-22M | · | $-22M | $-23M |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $21M | $31M | $30M | $98M | $36M | $23M | $33M | $25M | $56M | $58M | $42M | $39M | $34M | $54M | $56M | |
| Prepaid Expense | $5M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $7M | $8M | |
| Current Assets | $123M | $132M | $139M | $147M | $156M | $101M | $116M | $127M | $119M | $134M | $147M | $93M | $108M | $128M | $151M | $169M | |
| PP&E (Net) | $338.0K | $365.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $971.0K | $885.0K | $799.0K | $738.0K | $959.0K | $845.0K | $750.0K | $710.0K | $583.0K | |
| Other Non-current Assets | $29.0K | $73.0K | $117.0K | $161.0K | $205.0K | $249.0K | $293.0K | $337.0K | · | $0 | · | · | · | · | $0 | $10.0K | |
| Total Assets | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | $199M | |
| Accounts Payable | $3M | $579.0K | $975.0K | $771.0K | $3M | $4M | $2M | $763.0K | $1M | $2M | $694.0K | $3M | $3M | $2M | $6M | $2M | |
| Accrued Liabilities | $12M | $15M | $15M | $16M | $14M | $17M | $19M | $18M | $16M | $17M | $14M | $11M | $10M | $13M | $15M | $17M | |
| Current Liabilities | $15M | $16M | $16M | $17M | $17M | $21M | $21M | $18M | $17M | $20M | $15M | $14M | $13M | $15M | $21M | $20M | |
| Capital Leases | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $21M | $21M | $22M | $23M | $24M | $25M | $25M | $26M | $27M | |
| Total Liabilities | $29M | $31M | $32M | $34M | $35M | $39M | $40M | $39M | $38M | $42M | $38M | $38M | $37M | $41M | $47M | $46M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $578M | $577M | $576M | $574M | $572M | $570M | $568M | $567M | $540M | $534M | $533M | $458M | $455M | $453M | $450M | $447M | |
| Retained Earnings | $-474M | $-465M | $-450M | $-441M | $-431M | $-487M | $-471M | $-456M | $-436M | $-417M | $-398M | $-375M | $-356M | $-335M | $-314M | $-292M | |
| AOCI | $-36.0K | $101.0K | $142.0K | $-25.0K | $-19.0K | $24.0K | $107.0K | $-115.0K | $-95.0K | $-27.0K | $-364.0K | $-661.0K | $-1M | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $104M | $112M | $126M | $133M | $142M | $83M | $97M | $111M | $104M | $117M | $134M | $82M | $98M | $116M | $133M | $152M | |
| Liabilities + Equity | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | $199M | |
| Shares Outstanding | 57,301,774 | 57,138,057 | 56,943,413 | 56,886,939 | 56,676,716 | 56,644,655 | 56,521,914 | 56,408,487 | 52,527,626 | 51,645,557 | 51,635,184 | 36,533,525 | 36,511,947 | 36,434,297 | 36,366,206 | 36,315,737 |
Cash Flow 9
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-10M | $-7M | $-8M | $-9M | $53M | $-15M | $-11M | $-15M | $-21M | $-14M | $-18M | $-14M | $-20M | $-22M | $-16M | $-18M | |
| CapEx | · | · | · | · | · | · | · | · | · | $0 | $33.0K | $0 | $0 | $0 | $-8.0K | $193.0K | |
| Investing Cash Flow | $20M | $-3M | $9M | $-59M | $9M | $28M | $2M | $740.0K | $-14M | $12M | $-38M | $17M | $25M | $2M | $15M | $20M | |
| Stock Issued | · | $0 | $0 | $0 | $0 | $0 | $-500.0K | $21M | $4M | $0 | $72M | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | $4M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-185.0K | $-196.0K | $134.0K | $-116.0K | $32.0K | $291.0K | $-252.0K | $21M | $4M | $-46.0K | $72M | $0 | $51.0K | $-28.0K | $52.0K | $0 | |
| Net Change in Cash | $9M | $-10M | $874.0K | $-68M | $62M | $13M | $-9M | $7M | $-31M | $-2M | $16M | $3M | $5M | $-20M | $-2M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | $-20M | · | · | · |
Profitability 5
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | 80.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -5.9% | · | -5.8% | -6.7% | 35.5% | · | -10.0% | -14.8% | -13.1% | · | -13.0% | -12.0% | -11.8% | · | -9.5% | -9.4% | |
| ROE | -7.3% | · | -7.6% | -8.7% | 46.0% | · | -13.4% | -20.6% | -18.0% | · | -17.2% | -16.3% | -15.4% | · | -12.3% | -11.4% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.5 | · | 8.9 | 8.7 | 9.2 | · | 5.6 | 6.9 | 7.0 | · | 9.8 | 6.7 | 8.4 | · | 7.1 | 8.6 | |
| Quick Ratio | 2.1 | · | 2.0 | 1.8 | 5.8 | · | 1.1 | 1.8 | 1.5 | · | 3.8 | 3.0 | 3.0 | · | 2.6 | 2.8 |
Efficiency 1
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.4 | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | · | $70M | $70M | $70M | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | |
| Net Income TTM | $28M | · | $22M | $11M | $3M | · | $-77M | $-80M | $-81M | · | $-85M | $-85M | $-91M | · | $-105M | $-118M | |
| Market Cap | $122M | · | $216M | $141M | $88M | · | $246M | $263M | $266M | · | $148M | $184M | $69M | · | $61M | $89M | |
| P/E | 4.4 | · | 10.5 | 16.5 | -155.0 | · | -3.0 | -2.8 | -2.7 | · | -1.3 | -2.2 | -0.8 | · | -0.6 | -0.8 | |
| P/S | 1.7 | · | 3.1 | 2.0 | 1.3 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | 0.6 | |
| P / Tangible Book | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | 0.6 | |
| P / Cash Flow | -11.9 | · | · | · | 1.6 | · | · | · | -12.6 | · | · | · | -3.4 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | -3.4 | · | · | · | |
| Earnings Yield | 22.5% | · | 9.5% | 6.0% | -0.65% | · | -33.1% | -36.0% | -37.3% | · | -74.6% | -45.9% | -132.3% | · | -171.6% | -132.1% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $70M | $0 | — | — | — |
| Operating Margin % | 17.9% | — | — | — | — |
| Net Income | $22M | $-70M | $-82M | $-91M | $-126M |
| Diluted EPS | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 |
| Quick Ratio | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | $-62M | $-67M | $-85M | $-103M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.